IP Library Granted Patent US 11,479,810
Granted Patent B1
US 11,479,810 · App. 17/843,579 · Granted Oct 25, 2022

Spatially encoded biological assays

Inventor: Mark S. Chee (San Diego, CA)
Assignee: Prognosys Biosciences, Inc.
C12Q1/6837B01L3/502715C12Q1/68C12Q1/6804C12Q1/6809C12Q1/6834C12Q1/6841C12Q1/6869C12Q1/6874C12Q1/6876C40B30/04C40B60/04G01N33/5308G01N33/543G01N33/54366G01N33/6845G01N2458/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,479,810
App. No.
17/843,579
Granted
Oct 25, 2022
Kind
B1
Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

Claims (34)

1. A method of determining presence of a target biological molecule at multiple regions of interest in a tissue sample, comprising:

(a) delivering a plurality of probes to a tissue sample, wherein at least a subset of probes of the plurality of probes comprise a capture agent that specifically binds to a target biological molecule of the tissue sample, wherein the capture agent is conjugated to an oligonucleotide;

(b) separating the probes of the subset of probes comprising the capture agent specifically bound to the target biological molecule at the multiple regions of interest in the tissue sample from probes of the subset of probes not specifically bound to the target biological molecule at the multiple regions of interest in the tissue sample;

(c) removing the oligonucleotides from the probes comprising the capture agent specifically bound to the target biological molecule from the multiple regions of interest and determining a sequence of the oligonucleotides via hybridization of one or more labelled probe(s) comprising a label; and

(d) using the determined sequence of the oligonucleotides to determine presence of the target biological molecule at the multiple regions of interest in the tissue sample.

2. The method of claim 1 , wherein the method further comprises obtaining an image of the tissue sample.

3. The method of claim 1 , wherein step (b) comprises washing the tissue sample to separate the probes of the subset of probes comprising the capture agent specifically bound to the target biological molecule at the multiple regions of interest in the tissue sample from the probes of the subset of probes not specifically bound to the target biological molecule at the multiple regions of interest in the tissue sample.

4. The method of claim 1 , wherein step (c) comprises detecting the label of the one or more labelled probe(s).

5. The method of claim 1 , wherein the label of the one or more labelled probe(s) is a fluorophore.

6. The method of claim 5 , wherein step (c) comprises detecting the fluorophore.

7. The method of claim 1 , wherein the target biological molecule comprises a nucleic acid.

8. The method of claim 7 , wherein the nucleic acid is mRNA.

9. The method of claim 7 , wherein the nucleic acid is genomic DNA.

10. The method of claim 1 , wherein the target biological molecule comprises a protein.

11. The method of claim 10 , wherein the protein is an enzyme.

12. The method of claim 11 , wherein the enzyme comprises a kinase, a phosphatase, a zymogen, a protease, or a fragment thereof.

13. The method of claim 1 , wherein the capture agent is a small molecule, an aptamer, or a substrate for an enzyme.

14. The method of claim 1 , wherein the capture agent is an antibody.

15. The method of claim 1 , wherein two or more probes of the subset of probes specifically bind to unique target biological molecules of the tissue sample.

16. The method of claim 15 , wherein step (c) comprises determining all or a portion of the sequence of the oligonucleotides of the two or more probes of the subset of probes in parallel.

17. The method of claim 15 , wherein the two or more probes is at least one thousand probes.

18. The method of claim 1 , wherein the method further comprises detecting differential expression of the target biological molecule in the multiple regions of interest of the tissue sample.

19. The method of claim 18 , wherein the differential expression of the target biological molecule is associated with a biological structure or cell type.

20. The method of claim 18 , wherein the differential expression of the target biological molecule comprises gene expression.

21. The method of claim 18 , wherein the differential expression of the target biological molecule comprises protein expression.

22. The method of claim 1 , wherein the multiple regions of interest are determined by histological features of the tissue sample.

23. The method of claim 1 , wherein the tissue sample is a tissue section.

24. The method of claim 23 , wherein the tissue section comprises a fresh-frozen tissue section.

25. The method of claim 23 , wherein the tissue section comprises a formalin-fixed paraffin embedded tissue section.

26. The method of claim 1 , wherein the capture agent comprises a nucleic acid and the target biological molecule comprises an RNA.

27. The method of claim 1 , wherein the capture agent comprises a nucleic acid and the target biological molecule comprises a DNA.

28. The method of claim 1 , wherein the capture agent comprises an antibody and the target biological molecule comprises a protein.

29. The method of claim 1 , wherein the method further comprises obtaining an image of the tissue sample to identify the multiple regions of interest in the tissue sample.

30. The method of claim 1 , wherein the subset of probes of the plurality of probes comprise a capture agent that specifically binds to different target biological molecules of the tissue sample.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2022
From: CHEE, MARK S.
To: PROGNOSYS BIOSCIENCES, INC.
Reel/Frame 060313/0112 →
Continuity (7)
Continuation 17032317 · Sep 25, 2020
Continuation 16414213 · May 16, 2019
Continuation 16402098 · May 2, 2019
Continuation 16276235 · Feb 14, 2019
Continuation 15187661 · Jun 20, 2016
Continuation 13080616 · Apr 5, 2011
Provisional Application 61321124 · Apr 5, 2010
Cited By (37)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,399,123 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,475 US 12,637,706 US 12,692,492